MARKET

GRFS

GRFS

Grifols
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.10
-0.33
-1.70%
Opening 09:38 04/02 EDT
OPEN
19.27
PREV CLOSE
19.43
HIGH
19.48
LOW
18.92
VOLUME
31.51K
TURNOVER
--
52 WEEK HIGH
25.73
52 WEEK LOW
13.40
MARKET CAP
21.13B
P/E (TTM)
18.73
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GRFS stock price target is 26.75 with a high estimate of 26.75 and a low estimate of 26.75.

EPS

GRFS News

More
  • How Grifols (GRFS) Stock Stands Out in a Strong Industry
  • Zacks · 1d ago
  • The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger
  • Benzinga · 03/26 13:23
  • Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
  • PR Newswire · 03/25 22:25
  • Spain's Grifols to test plasma therapy for COVID-19 with U.S. FDA
  • Reuters · 03/25 20:55

Industry

Pharmaceuticals
-0.08%
Pharmaceuticals & Medical Research
-0.03%

Hot Stocks

Symbol
Price
%Change

About GRFS

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries, such as Kiro Grifols SL.
More

Webull offers kinds of Grifols SA - ADR stock information, including NASDAQ:GRFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRFS stock news, and many more online research tools to help you make informed decisions.